Commentary: innovation policy for a new era.
This commentary offers a response to the Sonderholm, Bird, and Flynn et al. articles, and argues that the current innovation crisis requires more ambitious approaches, as well as a serious consideration of alternative mechanisms for R&D such as prizes.
Kapczynski
Amy
A
University of California Berkeley School of Law, CA, USA.
D000900:Anti-Bacterial Agents / Q000600:supply & distribution*; D003906:Developing Countries; D055808:Drug Discovery / Q000191:economics* / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D004352:Drug Resistance, Microbial; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006297:Health Services Accessibility / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
D000900:Anti-Bacterial Agents